Select your timezone:
Room: Indigo 204

106.4 A novel subset of memory-like CD127highCD4+FOXP3+Treg found in porcine neonatal islet cell cluster (NICC) xenotransplant tolerant mice share similar features with tissue Tregs.

Award Winner

Haina Wang, Australia has been granted the TTS-CTRMS Congress Scientific Award

Haina Wang, Australia

Research Assistant
Westmead Institute for Medical Research

Abstract

A novel subset of memory-like CD127highCD4+FOXP3+Treg found in porcine neonatal islet cell cluster (NICC) xenotransplant tolerant mice share similar features with tissue Tregs

Haina Wang1, Zhuangzi Wang1, Yuanfei Zhao1, Leigh Nicholson1, Wayne J Hawthorne1, Elvira Jimenez-vera1, Brian Gloss2, Joey Lai2, Adwin Thomas1, Geoff Y Zhang3, Yuan Min Wang3, Natasha Rogers1, Guoping Zheng1, Shounan Yi1, Stephen I Alexander3, Philip J O’Connell1, Min Hu1.

1Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Sydney, Australia; 2Scientific Platforms, Westmead Institute for Medical Research, Sydney, Australia; 3Centre for Kidney Research, Children's Hospital at Westmead, Sydney, Australia

Introduction: CD4+Foxp3+regulatory T-cells (Tregs) are essential for islet xenotransplant tolerance. We identified a novel memory-like CD127+/highTreg subset in the spleen of tolerant mice following CTLA4-Fc/MR-1 induction and demonstrated their potent suppressive capacity in an adaptive-transfer mouse model. Our aims were to: (1) Further characterise CD127+/high Tregs. (2) Investigate transcriptional profile of CD4+Foxp3+Treg and non-Foxp3 CD4subsets in transplant tolerance.

Methods: DEpletion of REGulatory T-cells (DEREG) mice carrying a GFP transgene under a Foxp3 promoter were used as recipients in a porcine NICC xenotransplant model. Cell-subsets were selected with BD Influx Cell Sorter based on expression of CD4, GFP, and CD127 or CD45, CD4 and GFP. Bulk RNA-Seq and flow-cytometry profiled the transcriptomes and phenotypes of Treg subsets (CD127highTreg, CD127-/lowTreg, and all Treg) from the spleen (sp), draining lymph node (DLN) and grafts of tolerant-mice (day-100) compared to non-transplant mice. Quantitative PCR (qPCR) was used to assess expression of Il10/Tgfb1/Ifnγ/Il2/Il7//Il18//Il33/Ctla4 in spleen, ALN, DLN and graft cells of transplant mice (CTLA4-Fc/MR-1-treatment), rejection mice (no treatment) at day-8/100 and non-transplant mice. Imaging mass cytometry (17 antibodies) was used to evaluate the graft-infiltrating immune cells in tolerant-(day-8, 20, 100) and rejection-(day-8, 20) groups.

Results: A high proportion of CD127highTregs was observed in tolerant-grafts compared to tolerant-spleens [25.6±3.1% vs 14.8±0.4%]. Ebi3(IL-35), Il-10 and Blimp-1 expression were upregulated in splenic CD127highTregs of day-100 transplant-mice compared to naïve-Tregs. We identified 1740 differentially expressed genes (DEGs)(FDR<0.05) from 15 pairwise-comparisons that distinguished between CD45+CD4-, Foxp3-CD4+T-cells, and Treg subsets with: similar expression patterns between naive and tolerant CD45+CD4- cells; minor differences in Foxp3-CD4+T cells; and notable differences across Treg subsets where transcriptional profile was not uniform. Between different Treg subsets, 9 paired cross-comparisons identified 427 DEGs. In tolerant mice, both sp- and DLN-CD127+Tregs showed an effector/memory Treg profile. Compared to naïve-Treg or CD127-/lowTreg subsets, graft-Treg and CD127highTregs displayed upregulated DEGs including Il7r, Kctd12, Cxcr6, Ctla2a, Anxa1, H2-Ab, Klrk1, Klrg1, Ccl5, Id2, Ccr2, Adam8, Il18r1, Il1rl that have been reported in multiple tissue/tumour Treg subsets with memory features.  Additionally, measured by qPCR, increased Il7 expression and decreased Il2 expression in day-100 vs day-8 tolerant-graft suggest activated Tregs may preferentially utilise IL-7 or IL-35 over IL-2 (more broadly acting).

Conclusion: Memory-like CD127+/highTregs are critical for maintaining tolerance and may share a transcriptional trajectory with other tissue/tumour Tregs.

National Health and Medical Research Council (NHMRC; Grants: GNT1013185 & GNT1125456). JDRF/Australian Research Council (Grant: 4-SRA-2016-265-M-B). Westmead Scientific Platforms, Westmead Institute for Medical Research. Diabetes Australia (Grant: Y16G-HUMI). Department of Animal Care at Westmead Hospital. Cancer Institute New South Wales. Ian Potter Foundation. Ramaciotti Facility for Human Systems Biology. Sydney Cytometry, University of Sydney.

Organized by

Supported by

Hosted by


IPITA-IXA-CTRMS Joint Congress • San Diego, CA, USA • October 26-29, 2023
© 2024 IPITA-IXA-CTRMS 2023